Relationship Between Gastric Cancer Tau Protein Expression and Paclitaxel Sensitivity
Authors:
- 28 February 2013
- journal article
- research article
- Published by Springer Nature in Pathology and Oncology Research
- Vol. 19 (3) , 429-435
Abstract
The abnormal expression of Tau protein in breast cancer tissue affects paclitaxel sensitivity. The abnormal expression also exists in gastric carcinoma. Therefore, we speculate that the expression levels of Tau protein is closely related to paclitaxel sensitivity in gastric cancer, thus affecting the efficacy of paclitaxel. In this study, we used immunohistochemical methods to detect Tau protein expression levels in 47 cases of gastric cancer specimens. We also used Western blot to detect the level of Tau protein expression in gastric cancer cell lines and to check the efficacy of paclitaxel in vitro application. Findings indicate that Tau protein expression rate can reach as high as (+ +–+ + +) 63.83 % in gastric cancer. Paclitaxel induces inhibition and apoptosis with low expression of Tau protein in gastric cancer cell lines (P < 0.05). The level of Tau protein expression is significantly correlated with paclitaxel efficacy. If confirmed by further studies, the Tau protein can be another useful marker of gastric cancer, thereby leading to the application of paclitaxel in cancer treatment.Keywords
This publication has 14 references indexed in Scilit:
- Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trialBreast Cancer Research and Treatment, 2008
- Chemotherapy for advanced gastric cancer: across the years for a standard of careExpert Opinion on Pharmacotherapy, 2007
- Microtubule-Associated Protein-tau is a Bifunctional Predictor of Endocrine Sensitivity and Chemotherapy Resistance in Estrogen Receptor–Positive Breast CancerClinical Cancer Research, 2007
- Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study GroupJournal of Clinical Oncology, 2006
- Reduced tau expression in gastric cancer can identify candidates for successful Paclitaxel treatmentBritish Journal of Cancer, 2006
- Microtubule Associated Protein (MAP)-Tau: A Novel Mediator of Paclitaxel Sensitivity In Vitro and In VivoCell Cycle, 2005
- Microtubule-associated protein tau: A marker of paclitaxel sensitivity in breast cancerProceedings of the National Academy of Sciences, 2005
- Available options in chemotherapy for advanced gastric cancer: the current developments in JapanExpert Opinion on Pharmacotherapy, 2005
- [Development of research for drug-resistance mechanism of taxol].2002
- Expression of microtubule-associated protein tau by gastrointestinal stromal tumorsHuman Pathology, 2001